SAM #26-007652

Sole Source Notice – Bio-Rad CFX Opus 96 Real-Time PCR System and Reagents for NIH Clinical Center

This notice announces the NIH Clinical Center's intent to procure the Bio-Rad CFX Opus 96 Real-Time PCR System and compatible reagents from Bio-Rad Laboratories, Inc. on a sole source basis. - Agency: Department of Health and Human Services, National Institutes of Health, Clinical Center, Department of Laboratory Medicine - Sole source procurement: Only Bio-Rad Laboratories, Inc. is specified as the vendor and OEM - Products requested: - Bio-Rad CFX Opus 96 Real-Time PCR System - Compatible reagents for the system - No specific part numbers or quantities provided - Justification: Sole source required to maintain research integrity and comply with funded research plan - Acquisition method: FAR Part 13 Simplified Acquisition Procedures - Commercial opportunity: Interested parties may submit capability statements, but no formal solicitation will be issued - No service line items or additional equipment upgrades mentioned - Period of performance not specified

Description

The purpose of this procurement is to secure the instrument and reagents for the Bio-Rad CFX Opus 96 Real-Time PCR System to be used at the National Institutes of Health (NIH) Clinical Center (CC) Department of Laboratory Medicine (DLM)

•             Product Service Code: 6515 – Medical Instruments, Equipment, and Supplies

•             NAICS Code: 339112 – Surgical and Medical Instrument Manufacturing

•             Place of Performance: Bethesda, MD 20892 USA

POTS: 26-007652

Description:

This is a notice of intent, not a request for a quotation.  A solicitation document will not be issued and quotations will not be requested.

The National Institutes of Health (NIH) intends to award a fixed price purchase order to Bio-Rad Laboratories, Inc., located at 1000 Alfred Nobel Dr., Hercules, CA, 94547 on a firm fixed price sole source award basis to provide the required instrument and reagents to the National Institutes of Health DLM.

Funding for the research to be completed with the patient samples obtained through this contract is from the 2026 Research Award for Staff Clinicians (RASCL) Award to the NIH program. For the initial studies, a local PH center of excellence is required that has an institution affiliation with the IC. Thus, in order to maintain the integrity of the research plan and adhere to the proposed work that received funding, competition will be limited for this project.

This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available.  Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.

Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.

Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Kristin Nagashima, Contract Specialist via email to Kristin.nagashima@nih.gov by July 29, 2026 at 4pm EST.

View original listing